This country profile provides an overview of Senegal’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage increased from 62% in 2018 to 68% in 2019.
Senegal is conducting post-preventive chemotherapy surveillance.
Treatment coverage increased from 34% in 2018 to 70% in 2019.
Treatment coverage increased from 67% in 2018 to 76% in 2019.
Treatment coverage decreased from 94% in 2018 to 26% in 2019.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Senegal.